\u041f\u0440\u0435\u0441\u0442\u0438\u0436\u043d\u0438 \u043d\u0430\u0443\u0447\u043d\u0438 \u0438\u0437\u0434\u0430\u043d\u0438\u044f \u0441\u044a\u043e\u0431\u0449\u0430\u0432\u0430\u0442 \u0437\u0430 \u0441\u0435\u0440\u0438\u043e\u0437\u043d\u0438\u0442\u0435 \u0441\u0442\u0440\u0430\u043d\u0438\u0447\u043d\u0438 \u0435\u0444\u0435\u043a\u0442\u0438<\/p>\n\n\n\n
Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study:\u00a0DEFINE_ME<\/a> \u041f\u0440\u0435\u0441\u0442\u0438\u0436\u043d\u0438 \u043d\u0430\u0443\u0447\u043d\u0438 \u0438\u0437\u0434\u0430\u043d\u0438\u044f \u0441\u044a\u043e\u0431\u0449\u0430\u0432\u0430\u0442 \u0437\u0430 \u0441\u0435\u0440\u0438\u043e\u0437\u043d\u0438\u0442\u0435 \u0441\u0442\u0440\u0430\u043d\u0438\u0447\u043d\u0438 \u0435\u0444\u0435\u043a\u0442\u0438 Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study:\u00a0DEFINE_MEFatal cerebral hemorrhage after COVID-19 vaccine:\u00a0Fatal cerebral haemorrhage after COVID-19 vaccine – PubMedMyocarditis after mRNA vaccination against SARS-CoV-2, a case series:\u00a0Myocarditis following mRNA vaccination against SARS-CoV-2, a case seriesThree cases of acute venous thromboembolism in […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[850],"tags":[1050,1047],"class_list":["post-19088","post","type-post","status-publish","format-standard","hentry","category-haidut","tag-1050","tag-1047"],"yoast_head":"\n
Fatal cerebral hemorrhage after COVID-19 vaccine:\u00a0Fatal cerebral haemorrhage after COVID-19 vaccine – PubMed<\/a>
Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:\u00a0Myocarditis following mRNA vaccination against SARS-CoV-2, a case series<\/a>
Three cases of acute venous thromboembolism in women after vaccination against COVID-19:\u00a0Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019<\/a>
Acute thrombosis of the coronary tree after vaccination against COVID-19:\u00a0Acute Coronary Tree Thrombosis After Vaccination for COVID-19<\/a>
US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020:\u00a0US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 – PubMed<\/a>
Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine:\u00a0DEFINE_ME<\/a>
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET):\u00a0Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET) – PubMed<\/a>
Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review:\u00a0Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review<\/a>
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:\u00a0Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines<\/a>
Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma:\u00a0Covid-19 vaccine- induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma<\/a>
Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines:\u00a0Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines<\/a>
COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis:\u00a0COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis<\/a>
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid):\u00a0The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia<\/a>
Roots of autoimmunity of thrombotic events after COVID-19 vaccination:\u00a0Autoimmunity roots of the thrombotic events after COVID-19 vaccination<\/a>
Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience:\u00a0DEFINE_ME<\/a>
Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine:\u00a0https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejme2106315<\/a>
Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in \u201c23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine\u201d:\u00a0Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military<\/a>
Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19:\u00a0https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2104882?query=recirc_curatedRelated_article<\/a>
Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children:\u00a0Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children – PubMed<\/a>
Thrombotic thrombocytopenia after vaccination with ChAdOx1 nCov-19:\u00a0https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2104840?query=recirc_curatedRelated_article<\/a>
Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19):\u00a0Post-mortem findings in vaccine-induced thrombotic thombocytopenia | Haematologica<\/a>
Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS):\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0264410X21005247<\/a>
Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination:\u00a0https:\/\/pediatrics.aappublications.org\/content\/early\/2021\/06\/04\/peds.2021-052478<\/a>
Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man.\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2589238X21000292#f0005<\/a>
Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0896841121000895<\/a>
Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0049384821003315<\/a>
Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0896841121000937<\/a>
Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1052305721003098<\/a>
Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0953620521002363<\/a>
Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0828282X21006243<\/a>
\u201cPortal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome\u201d:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2666572721000389<\/a>
Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0196064421003425<\/a>
Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1443950621011562<\/a>
Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0896841121000706<\/a>
Prothrombotic immune thrombocytopenia after COVID-19 vaccination:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006497121009411<\/a>
Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2589936821000256<\/a>
Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1871402121002046<\/a>
Thrombosis after COVID-19 vaccination: possible link to ACE pathways:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0049384821004369<\/a>
Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109721051949<\/a>
A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735675721005714<\/a>
Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S088915912100163X<\/a>
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19):\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0006497121013963<\/a>.
Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel\u2019s back?:\u00a0https:\/\/docs.google.com\/document\/d\/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ<\/a>
Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0953620521002314<\/a>
Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0213485321000839<\/a>
Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the \u201cAstraZeneca COVID-19 vaccine\u201d:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33918932\/<\/a>
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33606296\/<\/a>
Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33854395\/<\/a>
Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7996471\/<\/a>
COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33863748\/<\/a>
Cerebral venous thrombosis associated with the covid-19 vaccine in Germany:\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.26172<\/a>
Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34133027\/<\/a>
The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34001390\/<\/a>
Thrombosis with thrombocytopenia after messenger RNA vaccine -1273:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34181446\/<\/a>
Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34174723\/<\/a>
First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland:\u00a0https:\/\/www.nature.com\/articles\/s41591-021-01408-4<\/a>
Exacerbation of immune thrombocytopenia after COVID-19 vaccination:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34075578\/<\/a>
First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34105244\/<\/a>
PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia:\u00a0https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMc2106383<\/a>
Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia:\u00a0https:\/\/www.nature.com\/articles\/s41586-021-03744-4<\/a>
Myocarditis with COVID-19 mRNA vaccines:\u00a0https:\/\/www.ahajournals.org\/doi\/pdf\/10.1161\/CIRCULATIONAHA.121.056135<\/a>
Myocarditis and pericarditis after COVID-19 vaccination:\u00a0https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2782900<\/a>
Myocarditis temporally associated with COVID-19 vaccination:\u00a0https:\/\/www.ahajournals.org\/doi\/pdf\/10.1161\/CIRCULATIONAHA.121.055891<\/a>.
COVID-19 Vaccination Associated with Myocarditis in Adolescents:\u00a0https:\/\/pediatrics.aappublications.org\/content\/pediatrics\/early\/2021\/08\/12\/peds.2021-053427.full.pdf<\/a>
Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33994339\/<\/a>
Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1553838921005789<\/a>
COVID-19 vaccine-induced myocarditis: a case report with review of the literature:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1871402121002253<\/a>
Potential association between COVID-19 vaccine and myocarditis: clinical and CMR findings:\u00a0https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936878X2100485X<\/a>
Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent:\u00a0<\/p>","protected":false},"excerpt":{"rendered":"